What is the current annual EBITDA of GSK?

As of today, GSK annual EBITDA is $9.11B

What is 1-year change in GSK annual EBITDA?

GSK annual EBITDA is down -19.36% year-over-year

What is 3-year change in GSK annual EBITDA?

GSK annual EBITDA is up +2.15% over the past 3 years

How far is GSK annual EBITDA from its all-time high?

GSK annual EBITDA is currently -53.74% below its historical high of $19.70B set on December 31, 2015

How does GSK annual EBITDA rank versus sector peers?

GSK annual EBITDA is higher than 98.64% of companies in Healthcare sector

When is GSK next annual earnings release?

The next annual earnings release for GSK is on February 4, 2026

What is the current quarterly EBITDA of GSK?

As of today, GSK quarterly EBITDA is $4.46B

What is GSK quarterly EBITDA most recent change?

GSK quarterly EBITDA was up +16.26% on September 1, 2025

What is 1-year change in GSK quarterly EBITDA?

GSK quarterly EBITDA is up +140.50% year-over-year

How far is GSK quarterly EBITDA from its all-time high?

GSK quarterly EBITDA is currently -9.38% below its historical high of $4.92B set on September 30, 2011

How does GSK quarterly EBITDA rank versus sector peers?

GSK quarterly EBITDA is higher than 99.10% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on February 4, 2026

What is the current TTM EBITDA of GSK?

As of today, GSK TTM EBITDA is $14.54B

What is GSK TTM EBITDA most recent change?

GSK TTM EBITDA was up +21.83% on September 1, 2025

What is 1-year change in GSK TTM EBITDA?

GSK TTM EBITDA is up +27.01% year-over-year

How far is GSK TTM EBITDA from its all-time high?

GSK TTM EBITDA is currently -18.41% below its historical high of $17.83B set on June 30, 2008

How does GSK TTM EBITDA rank versus sector peers?

GSK TTM EBITDA is higher than 98.82% of companies in Healthcare sector

When is GSK next earnings release?

The next earnings release for GSK is on February 4, 2026

GSK Plc (GSK) EBITDA History & Chart Since 1984

Annual EBITDA

$9.11B$2.19B-19.36%

December 31, 2024

Summary

Current Value: As of today, GSK annual EBITDA is $9.11B, down -19.36% on December 31, 2024
Historical Performance: GSK annual EBITDA is up +2.15% over the past 3 years, and down -24.34% over the past 5 years
All-Time High Comparison: GSK annual EBITDA is currently -53.74% below its historical high of $19.70B set on December 31, 2015
3-Year Low Comparison: GSK annual EBITDA is at its 3-year low
Sector Comparison: GSK annual EBITDA is higher than 98.64% of companies in Healthcare sector

EBITDA Chart

Add series to chart

Add series to chart1/6

Performance

GSK Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 24	$9.11B	-19.4%	+2.1%	-24.3%	-43.2%
Quarterly EBITDA	Sep 1, 25	$4.46B	+140.5%	+10.3%	+17.9%	+17.8%
TTM EBITDA	Sep 1, 25	$14.54B	+27.0%	+30.7%	+55.7%	+25.4%
Price	Jan 16, 26	$48.22	+44.2%	+36.3%	+22.9%	+20.7%
PE Ratio	Jan 16, 26	13.75	-34.9%	+241.2%	+27.4%	-57.3%
Annual Revenue	Dec 31, 24	$40.09B	+6.3%	+18.0%	-6.9%	-9.9%
Annual EPS	Dec 31, 24	$1.59	-46.7%	-57.3%	-46.2%	-62.6%
Annual EBIT	Dec 31, 24	$5.30B	-37.3%	-11.7%	-41.5%	-61.0%
Annual Net Income	Dec 31, 24	$3.77B	-42.9%	-22.0%	-43.9%	-57.6%

EBITDA Highs

GSK Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$11.30B	Dec 31, 23	-19.4%
5Y	$11.30B	Dec 31, 23	-19.4%
All	$19.70B	Dec 31, 15	-53.7%

EBITDA Lows

GSK Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$9.11B	Dec 31, 24	at low
5Y	$8.92B	Dec 31, 21	+2.1%
All	$0.00	Jun 1, 84	N/A

EBITDA History

Year	Value	Change
2024	$9.11B	-19.4%
2023	$11.30B	+6.1%
2022	$10.65B	+19.4%
2021	$8.92B	-13.8%
2020	$10.35B	-14.0%
2019	$12.05B	+22.8%
2018	$9.81B	+22.8%
2017	$7.98B	+33.0%
2016	$6.00B	-69.5%
2015	$19.70B	+131.8%
2014	$8.50B	-38.3%
2013	$13.77B	-1.3%
2012	$13.95B	-11.9%
2011	$15.84B	+82.8%
2010	$8.67B	-46.0%
2009	$16.03B	-0.7%
2008	$16.15B	-12.5%
2007	$18.46B	+14.3%
2006	$16.16B	+600.6%
2005	$2.31B	-81.0%
2004	$12.12B	+2.3%

Year	Value	Change
2003	$11.84B	+20.6%
2002	$9.82B	-1.4%
2001	$9.96B	-7.5%
2000	$10.77B	+107.5%
1999	$5.19B	-3.0%
1998	$5.36B	-0.5%
1997	$5.38B	-5.6%
1996	$5.70B	+10.9%
1995	$5.14B	+58.9%
1994	$3.23B	+1.7%
1993	$3.18B	+7.5%
1992	$2.96B	+5.6%
1991	$2.80B	+27.6%
1990	$2.19B	+13.6%
1989	$1.93B	+18.9%
1988	$1.62B	+31.1%
1987	$1.24B	+30.1%
1986	$951.97M	>+9,900.0%
1985	$0.00	0.0%
1984	$0.00	-

FAQ

What is the current annual EBITDA of GSK?
As of today, GSK annual EBITDA is $9.11B
What is 1-year change in GSK annual EBITDA?
GSK annual EBITDA is down -19.36% year-over-year
What is 3-year change in GSK annual EBITDA?
GSK annual EBITDA is up +2.15% over the past 3 years
How far is GSK annual EBITDA from its all-time high?
GSK annual EBITDA is currently -53.74% below its historical high of $19.70B set on December 31, 2015
How does GSK annual EBITDA rank versus sector peers?
GSK annual EBITDA is higher than 98.64% of companies in Healthcare sector
When is GSK next annual earnings release?
The next annual earnings release for GSK is on February 4, 2026

Quarterly EBITDA

$4.46B$624.05M+16.26%

September 1, 2025

Summary

Current Value: As of today, GSK quarterly EBITDA is $4.46B, up +16.26% on September 1, 2025
Historical Performance: GSK quarterly EBITDA is up +140.50% year-over-year, and up +10.29% over the past 3 years
All-Time High Comparison: GSK quarterly EBITDA is currently -9.38% below its historical high of $4.92B set on September 30, 2011
3-Year Low Comparison: GSK quarterly EBITDA is +290.53% above its 3-year low of $1.14B reached on an earlier date
Sector Comparison: GSK quarterly EBITDA is higher than 99.10% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 1, 25	$4.46B	+16.3%	+140.5%	+10.3%	+17.9%
Annual EBITDA	Dec 31, 24	$9.11B	–	-19.4%	+2.1%	-24.3%
TTM EBITDA	Sep 1, 25	$14.54B	+21.8%	+27.0%	+30.7%	+55.7%
Price	Jan 16, 26	$48.22	+10.2%	+44.2%	+36.3%	+22.9%
PE Ratio	Jan 16, 26	13.75	+10.2%	-34.9%	+241.2%	+27.4%
Quarterly Revenue	Sep 1, 25	$11.52B	+8.0%	+10.6%	+25.2%	+3.2%
Quarterly EPS	Sep 1, 25	$1.32	+41.1%	+3676.5%	-78.7%	+66.0%
Quarterly EBIT	Sep 1, 25	$3.47B	+51.4%	+460.2%	+40.0%	+17.3%
Quarterly Net Income	Sep 1, 25	$2.89B	+31.5%	+3321.0%	+215.7%	+56.5%

Quarterly EBITDA Highs

GSK Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$4.46B	Sep 1, 25	at high
3Y	$4.46B	Sep 1, 25	at high
5Y	$4.46B	Sep 1, 25	at high
All	$4.92B	Sep 30, 11	-9.4%

Quarterly EBITDA Lows

GSK Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$2.52B	N/A	+77.3%
3Y	$1.14B	N/A	+290.5%
5Y	$1.14B	Dec 31, 22	+290.5%
All	-$5.59B	Dec 31, 99	+179.8%

Quarterly EBITDA History

Month	Value	Change
Sep 2025	$4.46B	+16.3%
Jun 2025	$3.84B	+2.9%
Mar 2025	$3.73B	+48.3%
Dec 2024	$2.52B	+35.6%
Sep 2024	$1.86B	-44.0%
Jun 2024	$3.31B	+3.1%
Mar 2024	$3.21B	+4.4%
Dec 2023	$3.08B	-13.9%
Sep 2023	$3.57B	+33.4%
Jun 2023	$2.68B	-7.0%
Mar 2023	$2.88B	+152.0%
Dec 2022	$1.14B	-71.8%
Sep 2022	$4.05B	+45.9%
Jun 2022	$2.77B	+2.2%
Mar 2022	$2.71B	+69.4%
Dec 2021	$1.60B	-53.9%
Sep 2021	$3.47B	+29.3%
Jun 2021	$2.69B	+4.5%
Mar 2021	$2.57B	-19.2%
Dec 2020	$3.18B	-15.9%
Sep 2020	$3.78B	+1,661.8%
Jun 2020	$214.81M	-93.2%
Mar 2020	$3.15B	+43.5%
Dec 2019	$2.19B	-35.3%
Sep 2019	$3.39B	+3.3%
Jun 2019	$3.28B	-16.2%
Mar 2019	$3.92B	+39.0%
Dec 2018	$2.82B	-11.2%
Sep 2018	$3.18B	+28.9%
Jun 2018	$2.46B	-15.4%
Mar 2018	$2.91B	-1.2%
Dec 2017	$2.95B	-10.5%
Sep 2017	$3.30B	+19.8%
Jun 2017	$2.75B	+24.4%
Mar 2017	$2.21B	-9.9%
Dec 2016	$2.46B	-6.1%
Sep 2016	$2.62B	-8.5%
Jun 2016	$2.86B	+7.0%
Mar 2016	$2.67B	+5,768.5%
Dec 2015	$45.50M	-98.0%
Sep 2015	$2.33B	-20.3%
Jun 2015	$2.92B	+31.8%
Mar 2015	$2.21B	-38.6%
Dec 2014	$3.60B	+6.6%
Sep 2014	$3.38B	+28.2%
Jun 2014	$2.64B	-14.9%
Mar 2014	$3.10B	+549.2%
Dec 2013	-$689.39M	-117.3%
Sep 2013	$3.98B	+13.9%
Jun 2013	$3.49B	+0.6%
Mar 2013	$3.47B	-21.4%
Dec 2012	$4.41B	+39.9%
Sep 2012	$3.15B	-9.1%
Jun 2012	$3.47B	+9.4%
Mar 2012	$3.17B	+700.1%
Dec 2011	$396.66M	-91.9%
Sep 2011	$4.92B	+27.3%
Jun 2011	$3.87B	+21.7%
Mar 2011	$3.18B	+253.5%
Dec 2010	-$2.07B	-154.6%
Sep 2010	$3.79B	+487.3%
Jun 2010	$645.08M	-82.3%
Mar 2010	$3.65B	+4.1%
Dec 2009	$3.51B	-14.3%
Sep 2009	$4.09B	+31.2%
Jun 2009	$3.12B	-13.8%
Mar 2009	$3.62B	+7.0%
Dec 2008	$3.38B	+359.6%
Sep 2008	$735.66M	-83.1%
Jun 2008	$4.37B	-0.1%
Mar 2008	$4.37B	-3.7%
Dec 2007	$4.54B	-0.4%
Sep 2007	$4.56B	+10.1%
Jun 2007	$4.14B	-5.2%
Mar 2007	$4.36B	+37.8%
Dec 2006	$3.17B	-24.9%
Sep 2006	$4.22B	+3.5%
Jun 2006	$4.07B	-0.4%
Mar 2006	$4.09B	+26.0%
Dec 2005	$3.25B	-0.9%

Month	Value	Change
Sep 2005	$3.28B	-10.4%
Jun 2005	$3.66B	+10.8%
Mar 2005	$3.30B	+62.6%
Dec 2004	$2.03B	-37.6%
Sep 2004	$3.26B	+3.1%
Jun 2004	$3.16B	-4.9%
Mar 2004	$3.32B	-10.1%
Dec 2003	$3.69B	+8.8%
Sep 2003	$3.39B	+1.8%
Jun 2003	$3.33B	+6.6%
Mar 2003	$3.13B	+4.2%
Dec 2002	$3.00B	+18.1%
Sep 2002	$2.54B	-3.7%
Jun 2002	$2.64B	+9.6%
Mar 2002	$2.41B	-22.1%
Dec 2001	$3.09B	+36.1%
Sep 2001	$2.27B	-2.9%
Jun 2001	$2.34B	+32.5%
Mar 2001	$1.77B	-55.5%
Dec 2000	$3.97B	+138.9%
Sep 2000	$1.66B	-17.2%
Jun 2000	$2.00B	-7.6%
Mar 2000	$2.17B	+138.8%
Dec 1999	-$5.59B	-253.4%
Sep 1999	$3.65B	+197.7%
Jun 1999	$1.22B	-62.7%
Mar 1999	$3.29B	+164.4%
Dec 1998	-$5.11B	-250.1%
Sep 1998	$3.40B	+194.3%
Jun 1998	$1.16B	-63.7%
Mar 1998	$3.18B	+159.3%
Dec 1997	-$5.36B	-264.7%
Sep 1997	$3.25B	-1.1%
Jun 1997	$3.29B	-1.4%
Mar 1997	$3.34B	+217.3%
Dec 1996	-$2.85B	-173.6%
Sep 1996	$3.87B	+21.3%
Jun 1996	$3.19B	-2.1%
Mar 1996	$3.26B	+27.0%
Sep 1995	$2.56B	+148.1%
Jun 1995	-$5.33B	-310.9%
Mar 1995	$2.53B	-3.3%
Dec 1994	$2.61B	+3.3%
Sep 1994	$2.53B	+168.3%
Jun 1994	-$3.71B	-263.9%
Mar 1994	$2.26B	+6.6%
Dec 1993	$2.12B	+1.3%
Sep 1993	$2.09B	+164.8%
Jun 1993	-$3.23B	-245.0%
Mar 1993	$2.23B	+23.3%
Dec 1992	$1.81B	-2.9%
Sep 1992	$1.86B	+155.1%
Jun 1992	-$3.38B	-270.5%
Mar 1992	$1.98B	+7.2%
Dec 1991	$1.85B	-1.3%
Sep 1991	$1.87B	+207.3%
Jun 1991	-$1.75B	-215.4%
Mar 1991	$1.51B	+8.7%
Dec 1990	$1.39B	+1.5%
Sep 1990	$1.37B	+179.5%
Jun 1990	-$1.72B	-232.7%
Mar 1990	$1.30B	+8.8%
Dec 1989	$1.19B	+0.5%
Sep 1989	$1.19B	+197.3%
Jun 1989	-$1.22B	-219.8%
Mar 1989	$1.02B	+1.1%
Dec 1988	$1.01B	-1.1%
Sep 1988	$1.02B	+198.4%
Jun 1988	-$1.03B	-219.8%
Mar 1988	$863.72M	+6.1%
Dec 1987	$814.42M	-5.5%
Sep 1987	$862.23M	+200.4%
Jun 1987	-$858.44M	-220.2%
Mar 1987	$714.30M	+12.9%
Dec 1986	$632.59M	-6.0%
Sep 1986	$672.76M	+187.7%
Jun 1986	-$767.31M	-241.6%
Mar 1986	$542.04M	-1.2%
Dec 1985	$548.45M	+1.5%
Sep 1985	$540.44M	-

FAQ

What is the current quarterly EBITDA of GSK?
As of today, GSK quarterly EBITDA is $4.46B
What is GSK quarterly EBITDA most recent change?
GSK quarterly EBITDA was up +16.26% on September 1, 2025
What is 1-year change in GSK quarterly EBITDA?
GSK quarterly EBITDA is up +140.50% year-over-year
How far is GSK quarterly EBITDA from its all-time high?
GSK quarterly EBITDA is currently -9.38% below its historical high of $4.92B set on September 30, 2011
How does GSK quarterly EBITDA rank versus sector peers?
GSK quarterly EBITDA is higher than 99.10% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on February 4, 2026

TTM EBITDA

$14.54B$2.61B+21.83%

September 1, 2025

Summary

Current Value: As of today, GSK TTM EBITDA is $14.54B, up +21.83% on September 1, 2025
Historical Performance: GSK TTM EBITDA is up +27.01% year-over-year, and up +30.67% over the past 3 years
All-Time High Comparison: GSK TTM EBITDA is currently -18.41% below its historical high of $17.83B set on June 30, 2008
3-Year Low Comparison: GSK TTM EBITDA is +41.61% above its 3-year low of $10.27B reached on September 30, 2023
Sector Comparison: GSK TTM EBITDA is higher than 98.82% of companies in Healthcare sector

Performance

GSK Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 1, 25	$14.54B	+21.8%	+27.0%	+30.7%	+55.7%
Annual EBITDA	Dec 31, 24	$9.11B	–	-19.4%	+2.1%	-24.3%
Quarterly EBITDA	Sep 1, 25	$4.46B	+16.3%	+140.5%	+10.3%	+17.9%
Price	Jan 16, 26	$48.22	+10.2%	+44.2%	+36.3%	+22.9%
PE Ratio	Jan 16, 26	13.75	+10.2%	-34.9%	+241.2%	+27.4%
TTM Revenue	Sep 1, 25	$42.06B	+2.7%	+6.0%	+13.4%	-3.7%
TTM EPS	Sep 1, 25	$3.51	+63.4%	+128.1%	-59.0%	-12.9%
TTM EBIT	Sep 1, 25	$9.88B	+40.5%	+36.3%	+26.7%	+9.0%
TTM Net Income	Sep 1, 25	$7.96B	+54.4%	+121.5%	+66.2%	-11.3%

TTM EBITDA Highs

GSK TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$14.54B	Sep 1, 25	at high
3Y	$14.54B	Sep 1, 25	at high
5Y	$14.54B	Sep 1, 25	at high
All	$17.83B	Jun 30, 08	-18.4%

TTM EBITDA Lows

GSK TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$10.89B	N/A	+33.5%
3Y	$10.27B	Sep 30, 23	+41.6%
5Y	$9.75B	Mar 31, 21	+49.1%
All	$242.24M	Sep 30, 00	+5904.4%

TTM EBITDA History

Month	Value	Change
Sep 2025	$14.54B	+21.8%
Jun 2025	$11.94B	+4.6%
Mar 2025	$11.41B	+4.8%
Dec 2024	$10.89B	-4.9%
Sep 2024	$11.45B	-13.0%
Jun 2024	$13.17B	+5.1%
Mar 2024	$12.54B	+2.7%
Dec 2023	$12.20B	+18.8%
Sep 2023	$10.27B	-4.4%
Jun 2023	$10.74B	-0.9%
Mar 2023	$10.84B	+1.6%
Dec 2022	$10.67B	-4.1%
Sep 2022	$11.13B	+5.4%
Jun 2022	$10.56B	+0.8%
Mar 2022	$10.48B	+1.4%
Dec 2021	$10.33B	-13.3%
Sep 2021	$11.92B	-2.5%
Jun 2021	$12.22B	+25.3%
Mar 2021	$9.75B	-5.6%
Dec 2020	$10.33B	+10.6%
Sep 2020	$9.34B	+4.4%
Jun 2020	$8.95B	-25.5%
Mar 2020	$12.02B	-6.0%
Dec 2019	$12.79B	-4.6%
Sep 2019	$13.41B	+1.6%
Jun 2019	$13.20B	+6.6%
Mar 2019	$12.38B	+8.8%
Dec 2018	$11.37B	-1.1%
Sep 2018	$11.50B	-1.0%
Jun 2018	$11.62B	-2.4%
Mar 2018	$11.91B	+6.3%
Dec 2017	$11.21B	+4.6%
Sep 2017	$10.72B	+6.8%
Jun 2017	$10.04B	-1.1%
Mar 2017	$10.14B	-4.3%
Dec 2016	$10.60B	+29.4%
Sep 2016	$8.19B	+3.7%
Jun 2016	$7.90B	-0.7%
Mar 2016	$7.96B	+6.1%
Dec 2015	$7.50B	-32.2%
Sep 2015	$11.05B	-8.7%
Jun 2015	$12.11B	+2.4%
Mar 2015	$11.83B	-7.0%
Dec 2014	$12.71B	+51.0%
Sep 2014	$8.42B	-6.6%
Jun 2014	$9.02B	-8.7%
Mar 2014	$9.88B	-3.6%
Dec 2013	$10.25B	-33.2%
Sep 2013	$15.35B	+5.7%
Jun 2013	$14.53B	+0.1%
Mar 2013	$14.51B	+2.1%
Dec 2012	$14.21B	+39.4%
Sep 2012	$10.20B	-14.8%
Jun 2012	$11.97B	-3.2%
Mar 2012	$12.36B	-0.0%
Dec 2011	$12.36B	+24.9%
Sep 2011	$9.90B	+13.0%
Jun 2011	$8.76B	+58.1%
Mar 2011	$5.54B	-7.9%
Dec 2010	$6.02B	-48.1%
Sep 2010	$11.60B	-2.6%
Jun 2010	$11.90B	-17.2%
Mar 2010	$14.38B	+0.2%
Dec 2009	$14.34B	+0.9%
Sep 2009	$14.22B	+30.9%
Jun 2009	$10.86B	-10.3%
Mar 2009	$12.10B	-5.8%
Dec 2008	$12.85B	-8.3%
Sep 2008	$14.01B	-21.4%
Jun 2008	$17.83B	+1.3%
Mar 2008	$17.60B	+0.0%
Dec 2007	$17.59B	+8.5%
Sep 2007	$16.22B	+2.1%
Jun 2007	$15.88B	+0.4%
Mar 2007	$15.82B	+1.8%
Dec 2006	$15.55B	-0.5%
Sep 2006	$15.63B	+6.4%
Jun 2006	$14.69B	+2.9%
Mar 2006	$14.28B	+5.8%
Dec 2005	$13.49B	+9.9%

Month	Value	Change
Sep 2005	$12.28B	+0.2%
Jun 2005	$12.25B	+4.3%
Mar 2005	$11.75B	-0.1%
Dec 2004	$11.77B	-12.3%
Sep 2004	$13.42B	-1.0%
Jun 2004	$13.56B	-1.3%
Mar 2004	$13.73B	+1.4%
Dec 2003	$13.54B	+5.4%
Sep 2003	$12.85B	+7.1%
Jun 2003	$12.00B	+6.1%
Mar 2003	$11.31B	+6.8%
Dec 2002	$10.59B	-0.8%
Sep 2002	$10.68B	+2.6%
Jun 2002	$10.41B	+3.0%
Mar 2002	$10.11B	+6.8%
Dec 2001	$9.46B	-8.5%
Sep 2001	$10.34B	+6.3%
Jun 2001	$9.73B	+3.6%
Mar 2001	$9.40B	-4.1%
Dec 2000	$9.80B	+3,945.8%
Sep 2000	$242.24M	-89.1%
Jun 2000	$2.23B	+53.9%
Mar 2000	$1.45B	-43.6%
Dec 1999	$2.57B	-16.0%
Sep 1999	$3.05B	+8.8%
Jun 1999	$2.81B	+2.5%
Mar 1999	$2.74B	+4.1%
Dec 1998	$2.63B	+10.6%
Sep 1998	$2.38B	+6.6%
Jun 1998	$2.23B	-48.9%
Mar 1998	$4.37B	-3.5%
Dec 1997	$4.53B	-35.7%
Sep 1997	$7.04B	-8.0%
Jun 1997	$7.65B	+1.4%
Mar 1997	$7.55B	+1.1%
Dec 1996	$7.47B	-27.6%
Sep 1996	$10.31B	+14.5%
Jun 1996	$9.01B	+1,745.6%
Mar 1996	$488.17M	-79.4%
Sep 1995	$2.37B	+1.4%
Jun 1995	$2.34B	-41.0%
Mar 1995	$3.97B	+7.2%
Dec 1994	$3.70B	+15.4%
Sep 1994	$3.21B	+15.8%
Jun 1994	$2.77B	-14.6%
Mar 1994	$3.24B	+1.0%
Dec 1993	$3.21B	+10.8%
Sep 1993	$2.90B	+8.7%
Jun 1993	$2.66B	+5.8%
Mar 1993	$2.52B	+10.9%
Dec 1992	$2.27B	-1.8%
Sep 1992	$2.31B	-0.5%
Jun 1992	$2.33B	-41.3%
Mar 1992	$3.96B	+13.4%
Dec 1991	$3.49B	+15.1%
Sep 1991	$3.03B	+19.9%
Jun 1991	$2.53B	-0.9%
Mar 1991	$2.55B	+9.2%
Dec 1990	$2.34B	+9.3%
Sep 1990	$2.14B	+9.4%
Jun 1990	$1.96B	-20.5%
Mar 1990	$2.46B	+12.8%
Dec 1989	$2.18B	+9.3%
Sep 1989	$1.99B	+9.3%
Jun 1989	$1.82B	-9.2%
Mar 1989	$2.01B	+8.3%
Dec 1988	$1.85B	+11.6%
Sep 1988	$1.66B	+10.4%
Jun 1988	$1.51B	-10.5%
Mar 1988	$1.68B	+9.7%
Dec 1987	$1.53B	+13.5%
Sep 1987	$1.35B	+16.3%
Jun 1987	$1.16B	-7.3%
Mar 1987	$1.25B	+15.9%
Dec 1986	$1.08B	+8.4%
Sep 1986	$995.94M	+15.3%
Jun 1986	$863.62M	-47.0%
Mar 1986	$1.63B	+49.8%
Dec 1985	$1.09B	+101.5%
Sep 1985	$540.44M	-

FAQ

What is the current TTM EBITDA of GSK?
As of today, GSK TTM EBITDA is $14.54B
What is GSK TTM EBITDA most recent change?
GSK TTM EBITDA was up +21.83% on September 1, 2025
What is 1-year change in GSK TTM EBITDA?
GSK TTM EBITDA is up +27.01% year-over-year
How far is GSK TTM EBITDA from its all-time high?
GSK TTM EBITDA is currently -18.41% below its historical high of $17.83B set on June 30, 2008
How does GSK TTM EBITDA rank versus sector peers?
GSK TTM EBITDA is higher than 98.82% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on February 4, 2026

EBITDA Formula

EBITDA = Net Income + Interest Expense + Income Tax + Depreciation & Amortization

Data Sources & References

GSK Official Website www.gsk.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1131399/000113139925000007/0001131399-25-000007-index.htm
GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk